Comparison of sales price of Pralsetinib in the international market and domestic market

Pralsetinib (Pralsetinib), as a highly selective RET inhibitor, is widely used to treat patients with RET gene fusion-positive non-small cell lung cancer and thyroid cancer. The drug is currently on the market in China, but it has not yet been included in the medical insurance system, and patients need to purchase it at their own expense. In the domestic market, the original drug price of Platinib is relatively high, and the common specifications are 100mg×60 capsules and pan>100 mg Since it has not been included in the scope of medical insurance reimbursement, the financial burden on patients is relatively heavy.

Compared with domestic prices, the original drug price of platinib in overseas markets is more expensive. Depending on the pricing policies and exchange rate changes in different countries, the price of a box of 60 capsules fluctuates between 4 RMB 40,000 to more than 100,000 RMB. For example, the prices in the United States and Europe are generally on the high side. In some areas, because the drugs are innovative targeted therapies and do not yet have comprehensive government subsidies or insurance coverage, the cost of purchasing drugs for patients is considerable.

It is worth noting that with the continuous development and launch of generic drugs, generic versions of platinib with more advantageous prices have appeared in overseas markets. At present, generic drugs produced in Laos are relatively common. The specifications are 100mg This type of generic drugs provides more treatment options for patients with limited financial means, but they must be purchased through formal channels to ensure drug quality and efficacy.

Generally speaking, the international price of platinib is generally higher than that in China, and the emergence of generic drugs has greatly reduced the financial burden of some patients. When choosing a drug purchasing channel, patients should give priority to the legality and reliability of the drug source and avoid purchasing low-priced drugs from unknown sources. At the same time, it is recommended to use drugs rationally under the guidance of professional doctors, and scientifically plan drug purchase plans based on your own condition and economic situation.

Reference materials:https://www.drugs.com/